Építés alatt – nem éles oldal
Belépés
Befejeződött2/3. fázis

Effects of Standardized Boswellia Carterii Extract on Irritable Bowel Syndrome Patients

A legfontosabb adatok

Ki végzi
Mansoura University
Hol
Egyiptom1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Befejeződött
Fázis
2/3. fázis
Résztvevők
60 fő vett részt
Kezdés
2025. jan. 1.
Befejezés
2026. jan. 30.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Boswellia carterii Extract
  • Educationntal program for IBS patie
A regiszteradat frissítve
2026. május 8.

Ki vehet részt

Életkor
18 év – 65 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 2 feltétel megnézéseKevesebb

Ki vehet részt

  • Adults diagnosed with irritable bowel syndrome (IBS) according to Rome III and Rome IV criteria Recurrent abdominal pain occurring at least once weekly during the preceding three months Presence of changes in stool frequency, stool form, or defecation associated with abdominal pain Participants reporting bloating as the primary symptom

Ki nem vehet részt

  • Adherence to special diets (low-fat, lactose-free, or gluten-free diets) within the past six months Food allergies such as soy, nuts, or seafood allergies Insulin-dependent diabetes mellitus Celiac disease Inflammatory bowel disease History of major gastrointestinal surgery, including colonic surgery or cholecystectomy Bloody diarrhea, hematochezia, or melena Recent antibiotic use Presence of alarming gastrointestinal symptoms Severe renal disease Severe hepatic disease Pregnancy Breastfeeding

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Irritable bowel syndrome (IBS) is a common condition that affects the stomach and intestines. It can cause abdominal pain, bloating, diarrhea, constipation, and changes in bowel habits, which may reduce a person's quality of life. Many people with IBS do not achieve complete symptom relief with standard treatments.

A teljes eredeti leírásKevesebb

The purpose of this study is to evaluate whether a standardized Boswellia extract, combined with structured patient education, can help improve IBS symptoms and quality of life. Boswellia is a herbal extract that may help reduce inflammation and digestive discomfort.

In this study, 60 adults aged 18-39 years with moderate IBS were enrolled at Mansoura University Hospitals, Egypt. Participants received 500 mg of standardized Boswellia extract twice daily for 30 days and attended educational sessions about IBS self-management, including symptom control and healthy lifestyle practices.

Researchers evaluated abdominal pain, bloating, bowel habits, other gastrointestinal symptoms, and quality of life at the start of the study, after one week, and after one month to determine whether the intervention improved IBS symptoms and daily functioning.

A vizsgálat csoportja

  • Participants received 500 mg standardized Boswellia extract (≥65% boswellic acids) twice dailyA vizsgált kezelés

    Phytochemical standardization of the Boswellia carterii oleogum resin extract was conducted at the FAB-Lab (Faculty of Pharmacy, Mansoura University) to ensure batch-to-batch consistency and defined bioactive content. The extract was standardized to contain ≥65% total boswellic acids, based on previously established analytical and isolation methodologies developed in our laboratory. These procedures include chromatographic separation and characterization of immunomodulatory triterpenoids(7), as well as validation of leukotriene-inhibitory activity and bioactive compound profiling, as described in earlier pharmacological and clinical investigations of Boswellia preparations(8). The standardization approach has been consistently applied in prior experimental and clinical studies evaluating anti-inflammatory, immunomodulatory, antiviral, and osteoarthritis-related therapeutic effects of Boswellia-derived compounds, thereby ensuring reproducibility, phytochemical integrity, and biological

    Kezelés: Boswellia carterii Extract és Educationntal program for IBS patie

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
A Pilot Quasi-experimental Study Evaluating a Standardized Boswellia Carterii Extract Combined With Structured Patient Education in IBS
A regiszteradat frissítve
2026. május 8.